Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 6, 1999, Pages 723-728

  Calapai, G ^a   Crupi, A ^b   Firenzuoli, F ^b   Costantino, G ^a   Inferrera, G ^a   Campo, G M ^a   Caputi, A P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE; FLAVONOID; FLUOXETINE; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CONTROLLED STUDY; DEPRESSION; DIENCEPHALON; HYPERICUM PERFORATUM; MALE; MOOD; NONHUMAN; PATHOPHYSIOLOGY; RAT; SEROTONIN METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN STEM; CEREBRAL CORTEX; DIENCEPHALON; DOPAMINE; FLAVONOIDS; MALE; NOREPINEPHRINE; PERYLENE; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0032765281     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772862     Document Type: Article

References (30)

1. Barden, N. (1996) Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry 29: 12-22
2. Becker, T., Becker, G., Seufert, J., Hofmann, E., Lange, K. W., Naumann, M., Lindner, A., Reichmann, H., Riederer, P., Beckmann, H., Reiners, K. (1997) Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J. Neurol. Neurosurg. Psychiatry 63: 590-596
3. Bel, N., Artigas, F. (1993) Chronic treatment with fluvoxamine increases extracellular 5-hydroxytryptamine in frontal cortex but not in raphe nuclei. Synapse 15: 243-245
4. Bladt, S., Wagner, H. (1994) Inhibition of MAO by fractions and constituents of Hypericum extract. J. Geriatric. Psychiatr. Neurol. 7: S57-S59
5. Blier, P., de Montigny, C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15: 220-226
6. Bowden, C., Cheetam, S. C., Lowther, S., Katona, C. L., Crompton, M. R., Horton, R. W. (1997a) Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res. 769: 135-140
7. Bowden, C., Theodorou, A. E., Cheetam, S. C., Lowther, S., Katona, C. L., Crompton, M. R., Horton, R. W. (1997b) DA D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res. 752: 227-233
8. Brockmoller, J., Reum, T., Bauer, S., Kerb, R., Hubner, W. D., Roots, I. (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30 (Suppl. 2) 94-101
9. Butterweck, V., Wall, A., Liefländer-Wulf, U., Wintherhoff, A., Nahrstedt, A. (1997) Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30: S117-S124
10. Chatterjee, S. S., Bhattacharrya, S. K., Wonnemann, M., Singer, A., Müller, W. E. (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci. 63: 499-510
11. Demisch, L., Hölzl, J., Gollnick, B., Kacmarczyk, P. (1989) Identification of MAO-type-A inhibitors in Hypericum perforatum L. (Hyperforat). Pharmacopsychiatry 22: 194
12. De Saint Blanquat, G., Lambouef, Y., Fritsch, P. (1987) Determination of catecholamines in biological tissues by liquid chromatography with coulometric detection. J. Chromatogr. 415: 388-392
13. De Smet, P. A., Nolen, W. A. (1996) St. John's wort as an antidepressant. Br. Med. J. 313: 241-247
14. Gomez, F., De Kloet, E. R., Armario, A. (1998) Glucocorticoid negative feedback on the HPA axis in five inbred rat strains. Am. J. Physiol. 274: R420-R427
15. Holsboer, F., Spengler, D., Heuser, I. (1992) The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Progr. Brain Res. 93: 385-417
16. Kartnig, T., Gobel, I., Heydel, B. (1996) Production of hypericin, pseudohypericin and flavonoids in cell cultures of various Hypericum species and their chemotypes. Planta Med. 62: 51-53
17. Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., Melchart, D. (1997) St. John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br. Med. J. 313: 253-258
18. Lookmann, G., Schüle, C., Baghal, T., Kieser, M. (1998) St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31: S54-S59
19. Maes, M., Vandervost, C., Suy, E., Minner, B., Raus, J. (1991) A multivariate study on the simultaneous urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and β-endorphin escape from suppression by dexamethasone in melancholic patients. Acta Psychiatr. Scand. 83: 480-491
20. Mokrani, M. C., Duval, F., Crocq, M. A., Bailey, P., Macher, J. P. (1997) HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 22 (Suppl. 1): S63-S68
21. Montgomery, S. A. (1997) Is there a role for a pure noradrenergic drug in the treatment of depression? Eur. Neuropsychopharmacol. 7 (Suppl. 1): S3-S9
22. Mourilhe, P., Stokes, P. E. (1998) Risks and benefits of selective 5-hydroxytryptamine reuptake inhibitors in the treatment of depression. Drug Safety 18: 57-82
23. Müldner, H., Zöller, M. (1984) Antidepressive Wirkung eines auf den Wirkstoffkomplex Hypericin standardisierten Hypericum-Extraktes. Arzneim. Forsch. 34: 918-920
24. Nahrstedt, A., Butterweck, V. (1997) Biologically active and other chemical constituents of the herb of Hypericum perforatum. Pharmacopsychiatry 30: S129-S134
25. Özturk, Y. (1997) Testing the antidepressant effects of Hypericum species on animal models. Pharmacopsychiatry 30: 125-128
26. Perovic, S., Müller, W. E. G. (1995) Pharmacological profile of Hypericum extract: effect on 5-hydroxytryptamine uptake by receptors. Arzneim. Forsch. 45: 1145-1148
27. Seckl, J. R., Fink, G. (1991) Use of in situ hybridization to investigate the regulation of hippocampal corticosteroid receptors by monoamines. J. Steroid Biochem. Mol. Biol. 40: 685-688
28. G-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur. J. Pharmacol. 255: 51-55
29. Suzuki, O., Katsumata, Y., Oya, M., Bladt, S., Wagner, H. (1984) Inhibition of monoamine oxidase by hypericin. Planta Med. 50: 272-274
30. Thiede, H. M., Walper, A. (1994) Inhibition of MAO and COMT by Hypericum extract and hypericin. J. Geriatric. Psychiatr. Neurol. 7: S60-S62